Sonoma Pharmaceuticals (SNOA) Announces Pricing of $1.7 Million Public Offering of Common Stock Oct 26, 2023 09:13AM
Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock Oct 26, 2023 09:10AM
Sonoma Pharmaceuticals (SNOA) Announces 5M Share Offering Sep 19, 2023 04:33PM
Sonoma Pharmaceuticals Engages Maxim Group LLC to Explore Strategic Opportunities for its U.S. Dermatology Division Jan 23, 2020 04:43PM
Maxim Group Downgrades Sonoma Pharmaceuticals (SNOA) to Hold Mar 5, 2018 01:46PM


Feb 14, 2018 12:46PM Sonoma Pharmaceuticals (SNOA) PT Lowered to $7 at Maxim Group
Nov 10, 2017 07:38AM Sonoma Pharmaceuticals (SNOA) PT Raised to $11 at Maxim Group
Jun 6, 2017 07:53AM Sonoma Pharmaceuticals (SNOA) PT Raised to $10 at Maxim Group Following 4Q
Feb 10, 2017 07:57AM Sonoma Pharmaceuticals (SNOA) PT Raised to $9 at Maxim Group on Break Even Push